ENDO 2021
Endocrine Society's Annual Meeting 2021
March 20-23, 2021 |
Virtual
Pharmacological management of non-alcoholic fatty liver disease in patients with T2DM
Minimizing acute endocrinopathy associated with immune checkpoint inhibitors
Preserving bone integrity with the appropriate choice of hypoglycemic agents
Benefits of osteoporotic fracture prevention outweigh risks among postmenopausal women
Managing anorexia nervosa-associated low bone density in young women
Drugs in the pipelines for managing childhood and adolescent severe obesity
Teprotumumab for the treatment of active thyroid eye disease